{"id":"https://openalex.org/W2914767390","doi":"https://doi.org/10.1007/s40273-019-00767-8","title":"Cost Effectiveness of Inhaled Mannitol (Bronchitol\u00ae) in Patients with Cystic Fibrosis","display_name":"Cost Effectiveness of Inhaled Mannitol (Bronchitol\u00ae) in Patients with Cystic Fibrosis","publication_year":2019,"publication_date":"2019-01-22","ids":{"openalex":"https://openalex.org/W2914767390","doi":"https://doi.org/10.1007/s40273-019-00767-8","mag":"2914767390","pmid":"https://pubmed.ncbi.nlm.nih.gov/30666534"},"language":"en","primary_location":{"id":"doi:10.1007/s40273-019-00767-8","doi":"https://doi.org/10.1007/s40273-019-00767-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40273-019-00767-8","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060542597","display_name":"Emma Warren","orcid":"https://orcid.org/0000-0002-8866-421X","observed_orcids":["https://orcid.org/0000-0002-8866-421X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Emma Warren","raw_affiliation_strings":["HERA Consulting Australia Pty Ltd, 515 Darling Street, Balmain, NSW, 2041, Australia. emma@heraconsulting.com.au","HERA Consulting Australia Pty Ltd, 515 Darling Street, Balmain, NSW, 2041, Australia"],"raw_orcid":"https://orcid.org/0000-0002-8866-421X","affiliations":[{"raw_affiliation_string":"HERA Consulting Australia Pty Ltd, 515 Darling Street, Balmain, NSW, 2041, Australia. emma@heraconsulting.com.au","institution_ids":[]},{"raw_affiliation_string":"HERA Consulting Australia Pty Ltd, 515 Darling Street, Balmain, NSW, 2041, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kristen Morgan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163709","display_name":"Pharmaxis (Australia)","ror":"https://ror.org/054xyc945","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210163709"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Kristen Morgan","raw_affiliation_strings":["Pharmaxis Ltd, Frenchs Forest, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaxis Ltd, Frenchs Forest, Australia","institution_ids":["https://openalex.org/I4210163709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033149647","display_name":"Toby J. Toward","orcid":"https://orcid.org/0000-0002-4522-4994","observed_orcids":["https://orcid.org/0000-0002-4522-4994"]},"institutions":[{"id":"https://openalex.org/I4210163709","display_name":"Pharmaxis (Australia)","ror":"https://ror.org/054xyc945","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210163709"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Toby J. Toward","raw_affiliation_strings":["Henley Health Economics, Henley-on-Thames, UK","Pharmaxis Ltd, Frenchs Forest, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henley Health Economics, Henley-on-Thames, UK","institution_ids":[]},{"raw_affiliation_string":"Pharmaxis Ltd, Frenchs Forest, Australia","institution_ids":["https://openalex.org/I4210163709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072254367","display_name":"Matthias M. Schwenkglenks","orcid":"https://orcid.org/0000-0001-7217-1173","observed_orcids":["https://orcid.org/0000-0001-7217-1173"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Matthias Schwenkglenks","raw_affiliation_strings":["Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I1850255"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004271838","display_name":"Joanna Leadbetter","orcid":"https://orcid.org/0000-0002-0607-2975","observed_orcids":["https://orcid.org/0000-0002-0607-2975"]},"institutions":[{"id":"https://openalex.org/I4210163709","display_name":"Pharmaxis (Australia)","ror":"https://ror.org/054xyc945","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210163709"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Joanna Leadbetter","raw_affiliation_strings":["Pharmaxis Ltd, Frenchs Forest, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaxis Ltd, Frenchs Forest, Australia","institution_ids":["https://openalex.org/I4210163709"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5060542597"],"corresponding_institution_ids":[],"apc_list":{"value":3760,"currency":"USD","value_usd":3760},"apc_paid":null,"fwci":0.8835,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.73480258,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"37","issue":"3","first_page":"435","last_page":"446"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.7925000190734863,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.7925000190734863,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.20360000431537628,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.8899999856948853},{"id":"https://openalex.org/keywords/inhaled-mannitol","display_name":"inhaled mannitol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9570000171661377},{"id":"https://openalex.org/keywords/best-supportive-care","display_name":"best supportive care","score":0.8539999723434448},{"id":"https://openalex.org/keywords/pulmonary-exacerbations","display_name":"pulmonary exacerbations","score":0.9710000157356262},{"id":"https://openalex.org/keywords/lung-transplantation","display_name":"lung transplantation","score":0.7929999828338623},{"id":"https://openalex.org/keywords/dornase-alfa","display_name":"dornase alfa","score":0.8389999866485596},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.890999972820282},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.7509999871253967},{"id":"https://openalex.org/keywords/australian-healthcare-system","display_name":"Australian health system","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8170486092567444},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.6221392154693604},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5481064319610596},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.5312720537185669},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5179235339164734},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.5159524083137512},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4162788689136505},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.40074729919433594},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27536487579345703},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.10048991441726685},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D003850","descriptor_name":"Deoxyribonuclease I","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005541","descriptor_name":"Forced Expiratory Volume","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008353","descriptor_name":"Mannitol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008353","descriptor_name":"Mannitol","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1007/s40273-019-00767-8","doi":"https://doi.org/10.1007/s40273-019-00767-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40273-019-00767-8","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmid:30666534","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30666534","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:spr:pharme:v:37:y:2019:i:3:d:10.1007_s40273-019-00767-8","doi":null,"is_oa":false,"landing_page_url":"http://link.springer.com/10.1007/s40273-019-00767-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:edoc.unibas.ch:74375","doi":null,"is_oa":false,"landing_page_url":"https://edoc.unibas.ch/74375/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401836","display_name":"edoc (University of Basel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1850255","host_organization_name":"University of Basel","host_organization_lineage":["https://openalex.org/I1850255"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:www.zora.uzh.ch:177453","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/177453","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Warren, Emma; Morgan, Kristen; Toward, Toby J; Schwenkglenks, Matthias; Leadbetter, Joanna (2019). Cost Effectiveness of Inhaled Mannitol (Bronchitol$^{\u00ae}$) in Patients with Cystic Fibrosis. Pharmacoeconomics, 37(3):435-446.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/162380","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/162380","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Warren, E., Morgan, K., Toward, T. J., Schwenkglenks, M., & Leadbetter, J. (2019). Cost Effectiveness of Inhaled Mannitol (Bronchitol$^{\u00ae}$) in Patients with Cystic Fibrosis. Pharmacoeconomics, 37, 435\u2013446. https://doi.org/10.1007/s40273-019-00767-8","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1589654967","https://openalex.org/W1973960158","https://openalex.org/W1974992853","https://openalex.org/W2022954819","https://openalex.org/W2026040856","https://openalex.org/W2047080603","https://openalex.org/W2048091641","https://openalex.org/W2064804925","https://openalex.org/W2068207952","https://openalex.org/W2090222522","https://openalex.org/W2096991077","https://openalex.org/W2104379296","https://openalex.org/W2106250173","https://openalex.org/W2109577937","https://openalex.org/W2117042820","https://openalex.org/W2118744422","https://openalex.org/W2124798883","https://openalex.org/W2127482479","https://openalex.org/W2127779362","https://openalex.org/W2139675195","https://openalex.org/W2153807544","https://openalex.org/W2170978652","https://openalex.org/W2301131921","https://openalex.org/W2333398204","https://openalex.org/W2533936262","https://openalex.org/W2592166454","https://openalex.org/W2599873526","https://openalex.org/W2741096236","https://openalex.org/W2779156646","https://openalex.org/W2790252021","https://openalex.org/W2810933677"],"related_works":["https://openalex.org/W4230759257","https://openalex.org/W1028060797","https://openalex.org/W1932703961","https://openalex.org/W6979005300","https://openalex.org/W4292497486","https://openalex.org/W2017162760","https://openalex.org/W3133588053","https://openalex.org/W2001492346","https://openalex.org/W2124798883","https://openalex.org/W2592166454"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-02-21T00:00:00"}